Deep Lens

About:

Deep Lens focuses on enabling faster recruitment of cancer patients for clinical trials at the time of diagnosis.

Top Investors: Sierra Ventures, Service Provider Capital, Rev1 Ventures, Northpond Ventures, Tamarind Hill

Description:

Deep Lens is a provider of a digital pathology workflow platform intended to allow pathology groups to collaborate on groundbreaking cancer research. The company's platform includes AI-powered image detection and workflow support, collaboration, cloud storage, and built-in APIs for the ingestion of third-party AI models and integration to EMR, LIMS, and other systems, helping patients, pathologists, and physicians work together to accelerate and optimize treatment. Founded in 2017, Deep Lens is headquartered in Columbus, Ohio.

Total Funding Amount:

$17.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Columbus, Ohio, United States

Founded Date:

2017-01-01

Founders:

Dave Billiter, Simon Arkell, TJ Bowen

Number of Employees:

11-50